Relay Therapeutics Inc. Common Stock vs First Trust Cloud Computing ETF — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.59 (market cap $3.82B), while First Trust Cloud Computing ETF trades at $172.08 (market cap $3.47B). The key difference: Relay Therapeutics Inc. Common Stock and First Trust Cloud Computing ETF are close in size by market cap, and First Trust Cloud Computing ETF is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and First Trust Cloud Computing ETF for 84 Days on average.
| RLAY | SKYY | |
|---|---|---|
Market Cap | $3.82B | $3.47B |
Volume | 4,332,079 | 176,159 |
Sector | Health | — |
52-Week High | $20.75 | $171.01 |
52-Week Low | $6.03 | $104.16 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $2.93B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SKYY, the First Trust Cloud Computing ETF, trades at $170.78, down 0.13% on the day but near its 52-week high. Technical indicators show a bullish trend with strong moving average support, while oscillators are neutral. The fund provides diversified exposure to the cloud computing sector, benefiting from AI adoption and digital transformation trends. Recent news highlights a new 52-week high and institutional activity, reflecting positive momentum.
The outlook for SKYY is favorable, driven by secular growth in cloud infrastructure and AI demand. Key opportunities include exposure to hyperscaler capex and data center investments without heavy concentration in mega-cap tech. Risks involve sector volatility, competitive pressures, and macroeconomic sensitivity. Analyst sentiment is constructive, with the ETF positioned to capitalize on long-term technology shifts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →